Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2368
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBektas, Osman-
dc.contributor.authorGunaydin, Zeki Yuksel-
dc.contributor.authorKaragoz, Ahmet-
dc.contributor.authorOzer, Fahriye Feriha-
dc.date.accessioned2022-08-17T05:42:37Z-
dc.date.available2022-08-17T05:42:37Z-
dc.date.issued2016-
dc.identifier.urihttp://doi.org/10.1007/s00508-016-1026-5-
dc.identifier.urihttps://link.springer.com/article/10.1007%2Fs00508-016-1026-5-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2368-
dc.description.abstractSince levodopa was identified as an efficient therapeutic option in Parkinson disease (PD), great success has been achieved in the course and treatment of the disease. However, LaEurodopa-related side effects limit the therapeutic use in some patients. The aim of this study was to evaluate the effects of LaEurodopa therapy on left ventricular global systolic function via speckle tracking method. In this study, 55 patients with PD under LaEurodopa/dopa decarboxylase inhibitor therapy were compared with 30 age- and sex-matched control subjects. Conventional transthoracic echocardiography was performed in the left lateral position by two experienced operators in accordance with generally accepted guidelines. Left ventricular systolic function was analyzed by speckle tracking method using global longitudinal strain (GLS) and global circumferential strain (GCS) imaging. Adequate echocardiographic imaging for the evaluation of global longitudinal strain and global circumferential strain could be achieved in 55 of the patients. LVEF (left ventricular ejection fraction), GLS and GCS values were found to be similar between the patients with PD under LaEurodopa therapy and the control group (62 +/- 3.5 % vs 61 +/- 4 %, p < 0.05; -19.46 +/- 2.3 vs -19.4 +/- 3.2, p < 0.05; and -18.60 +/- 3.5 vs -18.22 +/- 3.2, p < 0.05 respectively.) Levodopa therapy has no unfavorable effect on left ventricular systolic function in patients with PD.en_US
dc.language.isoengen_US
dc.publisherSPRINGER WIEN, SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIAen_US
dc.relation.isversionof10.1007/s00508-016-1026-5en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectORTHOSTATIC HYPOTENSION; DIASTOLIC DYSFUNCTION; STANDARDS COMMITTEE; OF-ECHOCARDIOGRAPHY; MOTOR FLUCTUATIONS; SPECKLE TRACKING; HEART-FAILURE; L-DOPA; RECOMMENDATIONS; QUANTIFICATIONen_US
dc.subjectParkinson's disease; Levodopa; Speckle tracking echocardiographyen_US
dc.titleEffects of levodopa therapy on global left ventricular systolic function in patients with Parkinson diseaseen_US
dc.typearticleen_US
dc.relation.journalWIENER KLINISCHE WOCHENSCHRIFTen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0001-9779-7578en_US
dc.contributor.authorID0000-0002-0012-2708en_US
dc.contributor.authorID0000-0002-6616-9891en_US
dc.identifier.volume128en_US
dc.identifier.issue13-14en_US
dc.identifier.startpage528en_US
dc.identifier.endpage533en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.